您的购物车当前为空
别名 TSR-011
Belizatinib (TSR-011) 是可口服的ALK 和 TRKA、TRKB、TRKC 双重抑制剂,对野生型重组 ALK 的IC50值为0.7 nM。

Belizatinib (TSR-011) 是可口服的ALK 和 TRKA、TRKB、TRKC 双重抑制剂,对野生型重组 ALK 的IC50值为0.7 nM。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 338 | In stock | |
| 2 mg | ¥ 482 | In stock | |
| 5 mg | ¥ 828 | In stock | |
| 10 mg | ¥ 1,330 | In stock | |
| 25 mg | ¥ 2,660 | In stock | |
| 50 mg | ¥ 3,730 | In stock | |
| 100 mg | ¥ 4,970 | In stock | |
| 500 mg | ¥ 9,870 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 995 | In stock |
Belizatinib 相关产品
| 产品描述 | Belizatinib (TSR-011) is an effective, oral and dual inhibitor of ALK (IC50: 0.7 nM, wild-type recombinant ALK) and TRKA, TRKB, and TRKC. |
| 靶点活性 | ALK:0.7 nM |
| 体外活性 | 在临床试验中,Belizatinib具有抗肿瘤活性。 |
| 体内活性 | 在小鼠模型中,Belizatinib 能够持续且有效地抑制 ALK 依赖性的肿瘤生长。 |
| 别名 | TSR-011 |
| 分子量 | 577.73 |
| 分子式 | C33H44FN5O3 |
| CAS No. | 1357920-84-3 |
| Smiles | CC(C)NC(=O)[C@H]1CC[C@H](CC1)n1c(NC(=O)c2ccc(F)cc2)nc2ccc(CN3CCC(CC3)C(C)(C)O)cc12 |
| 密度 | 1.27 g/cm3 (Predicted) |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 60 mg/mL (103.85 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容